New drug treatments for cancer of the uterus
Some targeted therapy and immunotherapy drugs are being tested in clinical trials for people with endometrial cancer that has come back or not responded to treatment.
Targeted therapy is a drug treatment that attacks specific features of cancer cells to stop the cancer growing and spreading. Your medical oncologist may discuss testing the tumour to see whether there are any suitable targeted therapy drugs available through clinical trials.
Immunotherapy is a type of cancer treatment that uses the body’s own immune system to fight cancer. It may be an option for some endometrial cancers that have a fault in the mismatch repair (MMR) genes.
Ask your doctor about recent developments in drugs for uterine cancer and whether a clinical trial may be an option for you.
Watch this short video to learn more about drug therapies, including targeted therapy and immunotherapy.
Podcast: Immunotherapy & Targeted Therapy
Download a PDF booklet on this topic.
A/Prof Jim Nicklin, Director, Gynaecological Oncology, Royal Brisbane and Women’s Hospital, and Associate Professor Gynaecologic Oncology, The University of Queensland, QLD; Dr Robyn Cheuk, Senior Radiation Oncologist, Royal Brisbane and Women’s Hospital, QLD; Prof Michael Friedlander, Medical Oncologist, The Prince of Wales Hospital and Conjoint Professor of Medicine, The University of NSW, NSW; Kim Hobbs, Clinical Specialist Social Worker, Gynaecological Cancer, Westmead Hospital, NSW; Adele Hudson, Statewide Clinical Nurse Consultant, Gynaecological Oncology Service, Royal Hobart Hospital, TAS; Dr Anthony Richards, Gynaecological Oncologist, The Royal Women’s Hospital and Joan Kirner Women’s and Children’s Hospital, VIC; Georgina Richter, Gynaecological Oncology Clinical Nurse Consultant, Royal Adelaide Hospital, SA; Deb Roffe, 13 11 20 Consultant, Cancer Council SA.
View the Cancer Council NSW editorial policy.